Authors:
Monforte, AD
Bugarini, R
Pezzotti, P
De Luca, A
Antinori, A
Mussini, C
Vigevani, GM
Tirelli, U
Bruno, R
Gritti, F
Piazza, M
Chigiotti, S
Chirianni, A
De Stefano, C
Pizzigallo, E
Perrella, O
Moroni, M
Citation: Ad. Monforte et al., Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART, J ACQ IMM D, 28(2), 2001, pp. 114-123
Authors:
Ascherl, G
Sgadari, C
Bugarini, R
Bogner, J
Schatz, O
Ensoli, B
Sturzl, M
Citation: G. Ascherl et al., Serum concentrations of fibroblast growth factor 2 are increased in HIV type 1-infected patients and inversely related to survival probability, AIDS RES H, 17(11), 2001, pp. 1035-1039
Authors:
Suligoi, B
Tchamgmena, O
Sarmati, L
Bugarini, R
Toma, L
Bakary, DK
Glikoutou, M
Rezza, G
Citation: B. Suligoi et al., Prevalence and risk factors for herpes simplex virus type 2 infection among adolescents and adults in Northern Cameroon, SEX TRA DIS, 28(12), 2001, pp. 690-693
Authors:
Schatz, O
Monini, P
Bugarini, R
Neipel, F
Schulz, TF
Andreoni, M
Erb, P
Eggers, M
Haas, J
Butto, S
Lukwiya, M
Bogner, JR
Yaguboglu, S
Sheldon, J
Sarmati, L
Goebel, FD
Hintermaier, R
Enders, G
Regamey, N
Wernli, M
Sturzl, M
Rezza, G
Ensoli, B
Citation: O. Schatz et al., Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: Multicentre study with multiple and novel assays, J MED VIROL, 65(1), 2001, pp. 123-132
Authors:
Vigano, A
Pinti, M
Nasi, M
Moretti, L
Balli, F
Mussini, C
Bricalli, D
Sala, N
Bugarini, R
Vella, S
Principi, N
Cossarizza, A
Citation: A. Vigano et al., Markers of cell death-activation in lymphocytes of vertically HIV-infectedchildren naive to highly active antiretroviral therapy: The role of age, J ALLERG CL, 108(3), 2001, pp. 439-445
Authors:
Pezzotti, P
Monforte, AD
Bugarini, R
Rezza, G
Arici, C
Angarano, G
Borderi, M
Alberici, F
Armignacco, O
Menichetti, F
Prestileo, T
Sighinolfi, L
Sinicco, A
Resta, F
Vigevani, M
Ippolito, G
Citation: P. Pezzotti et al., Antiretroviral therapy in HIV-infected individuals in clinical practice: Are the criteria for initiating and choosing the type of drug regimen based only on immunologic and virologic values?, EUR J EPID, 16(10), 2000, pp. 919-926